Skip to content

Gross Profit at other companies

NeoGenomics logo
NeoGenomicsNEO
$80.86M+10.4%
Illumina logo
IlluminaILMN
$721M+5.6%
Veracyte logo
VeracyteVCYT
$101.16M+27.2%
GeneDx Holdings logo
GeneDx HoldingsWGS
$68.21M+16.6%
Quest Diagnostics logo
Quest DiagnosticsDGX
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Calculated from Personalis, Inc.’s reported figures.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s gross profit?
Personalis, Inc. (PSNL) reported gross profit of $281K in Q1 2026.
How has Personalis, Inc.'s gross profit changed year-over-year?
Personalis, Inc.'s gross profit decreased by 96.1% year-over-year, from $7.21M to $281K.
What is the long-term trend for Personalis, Inc.'s gross profit?
Over 4 years (2021 to 2025), Personalis, Inc.'s gross profit has grown at a -16.0% compound annual growth rate (CAGR), from $31.66M to $15.78M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.